Schedule 13G ownership disclosure

DOR BIOPHARMA INC

Security class unavailable · CUSIP: 258094101

Event date: 2014-09-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,608,354
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-14-007089
Form type
SC 13G
Filer
Hy Biopharma Inc
CIK
CIK 1407227
Filed
Oct 03, 2014
Reporting period
Sep 03, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub